| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6660 |
| Human Intestinal Absorption | HIA+ | 0.9223 |
| Caco-2 Permeability | Caco2+ | 0.7694 |
| P-glycoprotein Substrate | Non-substrate | 0.7212 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9848 |
| Non-inhibitor | 0.9937 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9221 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8503 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7994 |
| CYP450 2D6 Substrate | Non-substrate | 0.9202 |
| CYP450 3A4 Substrate | Non-substrate | 0.7442 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9258 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7325 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9698 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7879 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7558 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8568 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9648 |
| Non-inhibitor | 0.9776 |
| AMES Toxicity | Non AMES toxic | 0.9896 |
| Carcinogens | Non-carcinogens | 0.8818 |
| Fish Toxicity | High FHMT | 0.7970 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6014 |
| Honey Bee Toxicity | High HBT | 0.7274 |
| Biodegradation | Ready biodegradable | 0.8945 |
| Acute Oral Toxicity | III | 0.6994 |
| Carcinogenicity (Three-class) | Non-required | 0.8144 |